title: The in vitro and in vivo experimental evidences disclose the chemopreventive effects of Ganoderma lucidum on cancer invasion and metastasis.
abstract: The Ganoderma lucidum (Leyss. ex Fr.) Karst, an edible mushroom, has been utilized for centuries in East Asia to prevent or treat various diseases and to reduce the likelihood of cancer invasion and metastasis. The primary bioactive compounds are commonly considered to be polysaccharides and triterpenoids. Evidence that G. lucidum extract and its bioactive compounds may have a potential inhibitory effect on cancer invasion and metastasis is increasingly being reported in the scientific literature. This review assembles and summarizes past publications on the in vitro and in vivo effects of G. lucidum on cancer invasion and metastasis, and concludes that these effects occur through modulation of the phosphorylation of extracellular signal-regulated kinase (ERK1/2), phosphatidylinositol 3-kinase (PI 3-kinase) or Akt kinase (protein kinase B). Activation of these kinases subsequently inhibits the activity or expression of activator protein-1(AP-1) and nuclear factor-kappa B (NF-kappaB), resulting in the down-regulation of urokinase plaminogen activator (uPA), uPA receptor (uPAR), matrix metalloproteinase (MMP)-9, vascular endothelial growth factor (VEGF), transforming growth factor (TGF)-beta1, interleukin (IL)-8, inducible nitric oxide (NO) and beta1-integrin as shown in various cell lines or animal models. G. lucidum may be an effective nutraceutical used in the prevention of cancer metastasis. To further elucidate the bioactive components present in G. lucidum and the anti-metastatic mechanisms underlying these compounds, more in vitro and in vivo tests as well as clinical trials are necessary.
authors.affiliation: Graduate Institute of Applied Science of Living, Tainan University of Technology, 529 Jhongjheng Road, Yongkang, Tainan, 71002, Taiwan.
authors.forename: Chia-Jui
authors.initials: CJ
authors.lastname: Weng
authors.forename: Gow-Chin
authors.initials: GC
authors.lastname: Yen
mesh_terms: D000818:Animals; D006801:Humans; D066298:In Vitro Techniques; D009361:Neoplasm Invasiveness / Q000517:prevention & control*; D009362:Neoplasm Metastasis / Q000517:prevention & control*; D010936:Plant Extracts / Q000494:pharmacology*; D020940:Reishi / Q000737:chemistry*
chemical_list: D010936:Plant Extracts
references.citation: Bioorg Med Chem. 2002 Apr;10(4):1057-62
references.pmid: 11836115
references.citation: Anticancer Drugs. 2001 Jun;12(5):387-400
references.pmid: 11395568
references.citation: Arch Biochem Biophys. 2002 Dec 15;408(2):147-54
references.pmid: 12464265
references.citation: J Pharm Biomed Anal. 2008 Jul 15;47(3):469-77
references.pmid: 18337046
references.citation: Nat Rev Cancer. 2003 Jul;3(7):489-501
references.pmid: 12835669
references.citation: Nutr Cancer. 2005;53(1):11-7
references.pmid: 16351502
references.citation: J Ethnopharmacol. 2004 Jan;90(1):17-20
references.pmid: 14698502
references.citation: J Clin Oncol. 2000 Mar;18(5):1135-49
references.pmid: 10694567
references.citation: Curr Med Chem. 2000 Jul;7(7):715-29
references.pmid: 10702635
references.citation: Pharmacol Ther. 2003 Jul;99(1):113-32
references.pmid: 12804702
references.citation: Phytochemistry. 2006 Sep;67(18):1985-2001
references.pmid: 16905165
references.citation: Nature. 1993 Apr 29;362(6423):841-4
references.pmid: 7683111
references.citation: Cancer Lett. 2002 Aug 28;182(2):155-61
references.pmid: 12048161
references.citation: J Agric Food Chem. 2009 Jun 10;57(11):5049-57
references.pmid: 19422227
references.citation: Anticancer Res. 2002 Nov-Dec;22(6A):3309-18
references.pmid: 12530080
references.citation: J Nat Prod. 1991 Jul-Aug;54(4):998-1002
references.pmid: 1791484
references.citation: Beijing Da Xue Xue Bao Yi Xue Ban. 2007 Dec 18;39(6):653-6
references.pmid: 18087562
references.citation: Mini Rev Med Chem. 2008 Jun;8(7):677-88
references.pmid: 18537723
references.citation: Drug Discov Today. 2005 Dec;10(23-24):1584
references.pmid: 16376814
references.citation: Mol Nutr Food Res. 2007 Dec;51(12):1472-7
references.pmid: 17979098
references.citation: Int J Oncol. 2007 Apr;30(4):963-9
references.pmid: 17332936
references.citation: J Nat Prod. 2001 Aug;64(8):1121-2
references.pmid: 11520245
references.citation: Biochem Biophys Res Commun. 2002 Nov 8;298(4):603-12
references.pmid: 12408995
references.citation: Carcinogenesis. 2008 Jan;29(1):147-56
references.pmid: 18024477
references.citation: Int J Oncol. 2004 May;24(5):1093-9
references.pmid: 15067330
references.citation: Biochem Biophys Res Commun. 2005 Apr 29;330(1):46-52
references.pmid: 15781230
references.citation: Integr Cancer Ther. 2003 Dec;2(4):358-64
references.pmid: 14713328
references.citation: Perspect Biol Med. 2006 Spring;49(2):159-70
references.pmid: 16702701
references.citation: Chem Pharm Bull (Tokyo). 2004 Jun;52(6):688-95
references.pmid: 15187388
references.citation: Int J Mol Med. 2008 May;21(5):577-84
references.pmid: 18425349
references.citation: J Natl Cancer Inst. 1990 Jan 3;82(1):4-6
references.pmid: 1688381
references.citation: Int Immunopharmacol. 2007 Jun;7(6):864-70
references.pmid: 17466920
references.citation: Appl Microbiol Biotechnol. 2002 Nov;60(3):258-74
references.pmid: 12436306
references.citation: Acta Pharmacol Sin. 2004 Nov;25(11):1387-95
references.pmid: 15525457
references.citation: Nature. 1994 Feb 10;367(6463):576-9
references.pmid: 8107827
references.citation: Adv Cancer Res. 1990;54:159-211
references.pmid: 1688681
references.citation: Cancer Res. 1969 Mar;29(3):734-5
references.pmid: 5813100
references.citation: Cancer Chemother Pharmacol. 1999;43 Suppl:S42-51
references.pmid: 10357558
references.citation: Pharmacol Rep. 2010 Jan-Feb;62(1):150-63
references.pmid: 20360625
references.citation: Leuk Res. 2006 Jul;30(7):767-8
references.pmid: 16458355
references.citation: Cell. 1991 Jan 25;64(2):327-36
references.pmid: 1703045
references.citation: Matrix Biol. 1997 Mar;15(8-9):535-41
references.pmid: 9138286
references.citation: Int J Mol Med. 2006 Oct;18(4):657-64
references.pmid: 16964420
references.citation: J Pharmacol Sci. 2008 Oct;108(2):212-6
references.pmid: 18946196
references.citation: Biosci Biotechnol Biochem. 2008 Jun;72(6):1399-408
references.pmid: 18540114
references.citation: Acta Pharmacol Sin. 2004 Jun;25(6):833-8
references.pmid: 15169641
references.citation: J Nat Prod. 2004 Feb;67(2):300-10
references.pmid: 14987072
references.citation: FASEB J. 1999 May;13(8):781-92
references.pmid: 10224222
references.citation: Biosci Biotechnol Biochem. 2002 Dec;66(12):2626-31
references.pmid: 12596858
references.citation: Chem Biodivers. 2007 Feb;4(2):224-31
references.pmid: 17311233
references.citation: Chem Pharm Bull (Tokyo). 2002 Jun;50(6):837-40
references.pmid: 12045343
references.citation: Nat Rev Cancer. 2003 Dec;3(12):921-30
references.pmid: 14737122
references.citation: Exp Oncol. 2006 Mar;28(1):25-9
references.pmid: 16614703
references.citation: J Altern Complement Med. 2003 Aug;9(4):491-7
references.pmid: 14499024
references.citation: J Nat Prod. 1986 Jul-Aug;49(4):621-5
references.pmid: 3783158
references.citation: Immunopharmacology. 2000 May;47(2-3):63-83
references.pmid: 10878284
references.citation: Chem Rec. 2003;3(3):172-80
references.pmid: 12900937
references.citation: Chem Pharm Bull (Tokyo). 2000 Jul;48(7):1026-33
references.pmid: 10923835
references.citation: Adv Appl Microbiol. 1992;37:101-34
references.pmid: 1642155
references.citation: J Biol Chem. 2002 Feb 1;277(5):3150-7
references.pmid: 11689575
references.citation: J Pharmacol Sci. 2005 Oct;99(2):144-53
references.pmid: 16230843